Biosteon Intraline
Payments companies reported to CMS as associated with Biosteon Intraline. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Biosteon Intraline, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Biosteon Intraline
These are the largest totals companies reported as associated with Biosteon Intraline. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Steven Brown | Cedar Rapids, IA | Pediatric Orthopaedic Surgery | $54.69 |
| Cerise Rapp | Spokane Valley, WA | Medical | $51.25 |
| Brian Rebolledo | La Jolla, CA | Sports Medicine (Orthopaedic Surgery) | $51.25 |
| Omkar Dave | Jackson, MS | Sports Medicine (Orthopaedic Surgery) | $46.41 |
| Kelly Stephenson | Galveston, TX | Orthopaedic Surgery | $46.41 |
Prescribed Biosteon Intraline?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.